10 August 2022
ACCROL GROUP HOLDINGS PLC
("Accrol" or the "Group")
AIM: ACRL
Notice of Final Results and Online Presentations
Accrol, the UK's leading independent tissue converter, announces that it will release its Final Results for the year ended 30 April 2022 on Tuesday, 6 September 2022.
An analyst briefing will be held online at 9.00 am on that day. Equity analysts interested in joining the meeting should contact Belvedere Communications.
As part of the Group's Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Wednesday, 7 September 2022 at 12.30pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_FY22.
For further information, please contact:
|
Accrol Group Holdings plc Dan Wright, Executive Chairman Gareth Jenkins, Chief Executive Officer Richard Newman, Chief Financial Officer |
Via Belvedere Communications |
|
Zeus (Nominated Adviser & Broker) Dan Bate / Jordan Warburton (Investment Banking) Dominic King (Corporate Broking) |
Tel: +44 (0) 161 831 1512 Tel: +44 (0) 203 829 5000 |
|
Liberum Capital Limited (Joint Broker) Clayton Bush / Edward Thomas |
Tel: +44 (0) 20 3100 2222 |
|
Belvedere Communications Limited Cat Valentine Keeley Clarke |
Tel: +44 (0) 7715 769 078 Tel: +44 (0) 7967 816 525 |
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the £2.1bn UK retail tissue market.
For more information, please visit www.accrol.co.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDNORDGGDIRBGDGDC
The service was requested through Accrol Group Holdings. To modify your subscription, please subscribe again. If you no longer wish to receive these emails, you may unsubscribe at any time.
Supplied